Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy

Table 2

IL13Rα2-targeted immunotherapy.

Immunotherapy	References	Clinical trials
Monoclonal antibodies	[20, 24]	None
Pulsed dendritic cells	[21, 27]	NCT01280552 [28]
Chimeric antigen receptors	[22, 23, 39, 41]	NCT00730613 [37]; NCT01082926 [38]